Understanding C Difficile Infections


The State of the Science events allows experts to come together to update on recent research for CDI.

It is an interesting and important time for clostridium difficile infection (CDI) research, as the spread may be increasing, but new microbiome live therapeutics may be soon on the horizon.

With research and our understanding on the infectious disease changing almost daily it is important for investigators, doctors, and stakeholders to come together to share knowledge and theories whenever possible.

Recently, Teena Chopra, MD, MPH, Wayne State University, headlined HCPLive’s State of Science Program called Institutional Perspectives in Infectious Diseases: Management of C. Difficile.

Chopra was joined by Ammara Mushtaq, MD, Wayne State University, Bhagyashri Navalkele, MD, UMMC, and Avnish Sandhu, DO, Wayne State University.

The discussion included presentations on understanding C difficile infections, standards of care, emerging treatments, and an update on managing the disease.

Related Videos
Viability of Elamipretide for Geographic Atrophy in Dry AMD | Image Credit: HCPLive
Advancing Elamipretide into Phase 3 ReNEW and ReGAIN Trials | Image Credit: HCPLive
Elamipretide in ReCLAIM-2 Trial | Image Credit: HCPLive
A Promising Pipeline for COPD
Projecting Dupilumab's Fit in COPD
What the Ensifentrine FDA Approval Means for COPD
© 2024 MJH Life Sciences

All rights reserved.